218 related articles for article (PubMed ID: 6134754)
1. Adenosine deaminase messenger RNAs in lymphoblast cell lines derived from leukemic patients and patients with hereditary adenosine deaminase deficiency.
Adrian GS; Hutton JJ
J Clin Invest; 1983 Jun; 71(6):1649-60. PubMed ID: 6134754
[TBL] [Abstract][Full Text] [Related]
2. Cloning of cDNA sequences of human adenosine deaminase.
Wiginton DA; Adrian GS; Friedman RL; Suttle DP; Hutton JJ
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7481-5. PubMed ID: 6200875
[TBL] [Abstract][Full Text] [Related]
3. Characterization of normal and mutant adenosine deaminase messenger RNAs by translation and hybridization to a cDNA probe.
Adrian GS; Wiginton DA; Hutton JJ
Hum Genet; 1984; 68(2):169-72. PubMed ID: 6548726
[TBL] [Abstract][Full Text] [Related]
4. Genetic expression in partial adenosine deaminase deficiency. mRNA levels and protein turnover for the enzyme variants in human B-lymphoblast cell lines.
Daddona PE; Davidson BL; Perignon JL; Kelley WN
J Biol Chem; 1985 Mar; 260(6):3875-80. PubMed ID: 3871777
[TBL] [Abstract][Full Text] [Related]
5. Molecular biology of the adenosine deaminase gene and messenger RNA.
Hutton JJ; Wiginton DA
Ann N Y Acad Sci; 1985; 451():227-37. PubMed ID: 3865573
[TBL] [Abstract][Full Text] [Related]
6. Normal and mutant human adenosine deaminase genes.
Akeson AL; Wiginton DA; Hutton JJ
J Cell Biochem; 1989 Mar; 39(3):217-28. PubMed ID: 2651461
[TBL] [Abstract][Full Text] [Related]
7. Control of adenosine deaminase levels in human lymphoblasts.
Daddona PE; Kelley WN
Adv Enzyme Regul; 1982; 20():153-63. PubMed ID: 6981287
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
[TBL] [Abstract][Full Text] [Related]
9. Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein.
Valerio D; Duyvesteyn MG; van Ormondt H; Meera Khan P; van der Eb AJ
Nucleic Acids Res; 1984 Jan; 12(2):1015-24. PubMed ID: 6198631
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
Arredondo-Vega FX; Kurtzberg J; Chaffee S; Santisteban I; Reisner E; Povey MS; Hershfield MS
J Clin Invest; 1990 Aug; 86(2):444-52. PubMed ID: 1974554
[TBL] [Abstract][Full Text] [Related]
11. Genetic expression of adenosine deaminase in human lymphoid malignancies.
Gan TE; Dadonna PE; Mitchell BS
Blood; 1987 May; 69(5):1376-80. PubMed ID: 3567360
[TBL] [Abstract][Full Text] [Related]
12. Cell type-specific transcriptional regulation of the human adenosine deaminase gene.
Lattier DL; States JC; Hutton JJ; Wiginton DA
Nucleic Acids Res; 1989 Feb; 17(3):1061-76. PubMed ID: 2784203
[TBL] [Abstract][Full Text] [Related]
13. Phorbol esters induce changes in adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyl transferase messenger RNA levels in human leukemic cell lines.
Madrid-Marina V; Martinez-Valdez H; Cohen A
Cancer Res; 1990 May; 50(10):2891-4. PubMed ID: 2110502
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactive protein in adenosine deaminase deficient human lymphoblast cell lines.
Wiginton DA; Hutton JJ
J Biol Chem; 1982 Mar; 257(6):3211-7. PubMed ID: 6977542
[TBL] [Abstract][Full Text] [Related]
15. A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.
Uberti J; Peterson WD; Lightbody JJ; Johnson RM
J Immunol; 1983 Jun; 130(6):2866-70. PubMed ID: 6854019
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W
J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373
[TBL] [Abstract][Full Text] [Related]
17. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
Goday A; Simmonds HA; Morris GS; Fairbanks LD
Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing.
Akeson AL; Wiginton DA; States JC; Perme CM; Dusing MR; Hutton JJ
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5947-51. PubMed ID: 3475710
[TBL] [Abstract][Full Text] [Related]
19. Adenosine deaminase activity of normal lymphocytes and leukemic cells.
Ben-Bassat I; Simoni F; Holtzman F; Ramot B
Isr J Med Sci; 1979 Nov; 15(11):925-7. PubMed ID: 118945
[TBL] [Abstract][Full Text] [Related]
20. Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer.
Kantoff PW; Kohn DB; Mitsuya H; Armentano D; Sieberg M; Zwiebel JA; Eglitis MA; McLachlin JR; Wiginton DA; Hutton JJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6563-7. PubMed ID: 3489233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
